PTKFY
Price
$13.57
Change
+$0.80 (+6.26%)
Updated
Feb 3 closing price
Capitalization
3.11B
Intraday BUY SELL Signals
RHHBY
Price
$56.58
Change
+$11.04 (+24.24%)
Updated
Feb 3 closing price
Capitalization
361.01B
78 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PTKFY vs RHHBY

Header iconPTKFY vs RHHBY Comparison
Open Charts PTKFY vs RHHBYBanner chart's image
PT Kalba Farma TBK
Price$13.57
Change+$0.80 (+6.26%)
Volume$125
Capitalization3.11B
Roche Holding
Price$56.58
Change+$11.04 (+24.24%)
Volume$1.03M
Capitalization361.01B
PTKFY vs RHHBY Comparison Chart in %
PTKFY
Daily Signal:
Gain/Loss:
RHHBY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PTKFY vs. RHHBY commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTKFY is a Hold and RHHBY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (PTKFY: $13.57 vs. RHHBY: $56.58)
Brand notoriety: PTKFY and RHHBY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: PTKFY: 41% vs. RHHBY: 39%
Market capitalization -- PTKFY: $3.11B vs. RHHBY: $361.01B
PTKFY [@Pharmaceuticals: Major] is valued at $3.11B. RHHBY’s [@Pharmaceuticals: Major] market capitalization is $361.01B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $898.12B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $114.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PTKFY’s FA Score shows that 2 FA rating(s) are green whileRHHBY’s FA Score has 1 green FA rating(s).

  • PTKFY’s FA Score: 2 green, 3 red.
  • RHHBY’s FA Score: 1 green, 4 red.
According to our system of comparison, RHHBY is a better buy in the long-term than PTKFY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PTKFY’s TA Score shows that 5 TA indicator(s) are bullish while RHHBY’s TA Score has 3 bullish TA indicator(s).

  • PTKFY’s TA Score: 5 bullish, 3 bearish.
  • RHHBY’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, PTKFY is a better buy in the short-term than RHHBY.

Price Growth

PTKFY (@Pharmaceuticals: Major) experienced а -5.07% price change this week, while RHHBY (@Pharmaceuticals: Major) price change was -0.19% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.82%. For the same industry, the average monthly price growth was +4.65%, and the average quarterly price growth was +18.14%.

Reported Earning Dates

RHHBY is expected to report earnings on Apr 23, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (+1.82% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHBY($361B) has a higher market cap than PTKFY($3.11B). RHHBY has higher P/E ratio than PTKFY: RHHBY (21.99) vs PTKFY (14.86). RHHBY YTD gains are higher at: 9.715 vs. PTKFY (0.519). PTKFY has higher annual earnings (EBITDA): 5.02T vs. RHHBY (18B). PTKFY has more cash in the bank: 4.2T vs. RHHBY (12B). RHHBY has less debt than PTKFY: RHHBY (33B) vs PTKFY (520B). PTKFY has higher revenues than RHHBY: PTKFY (34.38T) vs RHHBY (63.5B).
PTKFYRHHBYPTKFY / RHHBY
Capitalization3.11B361B1%
EBITDA5.02T18B27,878%
Gain YTD0.5199.7155%
P/E Ratio14.8621.9968%
Revenue34.38T63.5B54,137%
Total Cash4.2T12B35,000%
Total Debt520B33B1,576%
FUNDAMENTALS RATINGS
PTKFY vs RHHBY: Fundamental Ratings
PTKFY
RHHBY
OUTLOOK RATING
1..100
2716
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
17
Undervalued
PROFIT vs RISK RATING
1..100
10047
SMR RATING
1..100
1499
PRICE GROWTH RATING
1..100
6239
P/E GROWTH RATING
1..100
7949
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PTKFY's Valuation (12) in the null industry is in the same range as RHHBY (17). This means that PTKFY’s stock grew similarly to RHHBY’s over the last 12 months.

RHHBY's Profit vs Risk Rating (47) in the null industry is somewhat better than the same rating for PTKFY (100). This means that RHHBY’s stock grew somewhat faster than PTKFY’s over the last 12 months.

PTKFY's SMR Rating (14) in the null industry is significantly better than the same rating for RHHBY (99). This means that PTKFY’s stock grew significantly faster than RHHBY’s over the last 12 months.

RHHBY's Price Growth Rating (39) in the null industry is in the same range as PTKFY (62). This means that RHHBY’s stock grew similarly to PTKFY’s over the last 12 months.

RHHBY's P/E Growth Rating (49) in the null industry is in the same range as PTKFY (79). This means that RHHBY’s stock grew similarly to PTKFY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PTKFYRHHBY
RSI
ODDS (%)
Bullish Trend 2 days ago
50%
Bearish Trend 2 days ago
47%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
42%
Bearish Trend 2 days ago
42%
Momentum
ODDS (%)
Bearish Trend 2 days ago
46%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
32%
Bullish Trend 2 days ago
62%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
49%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
23%
Bullish Trend 2 days ago
53%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
55%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
56%
Bearish Trend 2 days ago
30%
Aroon
ODDS (%)
Bullish Trend 2 days ago
33%
Bullish Trend 2 days ago
48%
View a ticker or compare two or three
Interact to see
Advertisement
PTKFY
Daily Signal:
Gain/Loss:
RHHBY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GEMCX27.410.32
+1.18%
Goldman Sachs Emerging Markets Eq C
IRSIX13.920.05
+0.36%
Voya Russell Small Cap Index Port A
CFMCX12.53N/A
N/A
Column Mid Cap
PAMCX90.88-1.04
-1.13%
T. Rowe Price Mid-Cap Growth Adv
PFPGX27.48-0.68
-2.41%
Parnassus Growth Equity Institutional

PTKFY and

Correlation & Price change

A.I.dvisor tells us that PTKFY and SNPHF have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTKFY and SNPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTKFY
1D Price
Change %
PTKFY100%
-5.07%
SNPHF - PTKFY
6%
Poorly correlated
N/A
RHHVF - PTKFY
4%
Poorly correlated
-0.53%
RHHBY - PTKFY
2%
Poorly correlated
-0.95%
RHHBF - PTKFY
1%
Poorly correlated
+0.27%
OTSKF - PTKFY
0%
Poorly correlated
N/A
More

RHHBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHBY has been loosely correlated with RHHVF. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHBY jumps, then RHHVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHBY
1D Price
Change %
RHHBY100%
-0.95%
RHHVF - RHHBY
65%
Loosely correlated
-0.53%
NVS - RHHBY
37%
Loosely correlated
-0.78%
JNJ - RHHBY
37%
Loosely correlated
+1.02%
RHHBF - RHHBY
32%
Poorly correlated
+0.27%
BMY - RHHBY
28%
Poorly correlated
+0.18%
More